| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/10/2008 | US20080085835 Rps gene family, primers, probes and detection methods |
| 04/10/2008 | US20080085557 Human Cancer Stem Cell Culture Compositions Comprising Erbb2 Variants and Methods of use Thereof |
| 04/10/2008 | US20080085539 Expression vector comprising yeast secretory leader sequence, biotin acceptor site for golgi-localized biotin ligase and yeast replication origin for use as tool in expression of heterologous gene sequences in yeast cells |
| 04/10/2008 | US20080085538 Methods for Expression and Purification of Recombinant Human Growth Hormone |
| 04/10/2008 | US20080085531 Antagonistic anti-human CD40 monoclonal antibody |
| 04/10/2008 | US20080085510 Human ron-related gene variant associated with cancers |
| 04/10/2008 | US20080085282 Methods of detecting and controlling mucoid pseudomonas biofilm production |
| 04/10/2008 | US20080085280 Using monoclonal antibody specific to bacterial ectodomain as tool in prevention and treatment of pancreatic, kidney and inflammatory disorders |
| 04/10/2008 | US20080085279 Murine double mutant binding protein (MTBP) inhibitor for use as tool in treatment and prevention of cell proliferative disorders |
| 04/10/2008 | US20080085278 Binding member which binds to both lewis-y and lewis-b haptens, and its use for treating cancer |
| 04/10/2008 | US20080085277 Novel antigen-binding polypeptides and their uses |
| 04/10/2008 | US20080085266 Using cancer antigen 125 as tool in generating transmembrane serine protease inhibitory compound for treatment of urogenital cell proliferative disorders |
| 04/10/2008 | US20080085262 Purified mammalian cytokines; related reagents and methods |
| 04/10/2008 | US20080085241 highly selective; tumor-specific binding proteins; amino acid sequence; nucleic acid molecule; recombinant expression vector; host cell; cancer diagnosis; identify only those markers recognized by the human immune system as sufficiently foreign to trigger the production of antibodies; antigen is CD98hc |
| 04/10/2008 | CA2847007A1 Process for the production of polyunsaturated fatty acids in transgenic organisms |
| 04/10/2008 | CA2665447A1 Human antibodies neutralizing human metapneumovirus |
| 04/10/2008 | CA2665351A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 04/10/2008 | CA2665037A1 Human epo receptor agonists, compositions, methods and uses for preventing or treating glucose intolerance related conditions |
| 04/10/2008 | CA2664738A1 Compositions and methods for diagnosing and treating cancer |
| 04/10/2008 | CA2664681A1 Design and construction of diverse synthetic peptide and polypeptide libraries |
| 04/10/2008 | CA2658618A1 Novel gene disruptions, compositions and methods relating thereto |
| 04/10/2008 | CA2653628A1 Neuroactive fragments of app |
| 04/09/2008 | EP1908839A2 Virulence genes, proteins, and their use |
| 04/09/2008 | EP1908837A2 Human receptor proteins, related reagents and methods |
| 04/09/2008 | EP1908836A1 Novel G protein-coupled receptor proteins |
| 04/09/2008 | EP1908834A2 Heteromultimeric ion channel receptor and uses thereof |
| 04/09/2008 | EP1908825A1 ANTIBODY DIRECTED AGAINST PAP2a AND USE THEREOF FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES |
| 04/09/2008 | EP1908772A2 Porphorymonas gingivalis polypeptides and polynucleotides |
| 04/09/2008 | EP1908769A1 A system for antibody expression and assembly |
| 04/09/2008 | EP1908479A2 Anti-p53 Antibodies |
| 04/09/2008 | EP1907426A2 Novel anti-igf-ir antibodies and uses thereof |
| 04/09/2008 | EP1907425A2 Anti-cd26 antibodies and methods of use thereof |
| 04/09/2008 | EP1907424A2 Human monoclonal antibodies to programmed death ligand 1 (pd-l1) |
| 04/09/2008 | EP1907423A2 Catalytic immunoglobulins |
| 04/09/2008 | EP1907421A2 Il-12/p40 binding proteins |
| 04/09/2008 | EP1907420A2 Plexin d1 as a target for tumor diagnosis and therapy |
| 04/09/2008 | EP1907002A2 Methods of treating autoimmune disease using humanized anti-cd16a antibodies |
| 04/09/2008 | EP1907001A2 Ilt3 binding molecules and uses therefor |
| 04/09/2008 | EP1906999A1 Frizzled 9 as tumour marker |
| 04/09/2008 | EP1906990A1 Anticoagulation agent and uses thereof |
| 04/09/2008 | EP1906976A2 Therapeutic polymers and methods of use |
| 04/09/2008 | EP1906725A2 Enhancement of hydroxy fatty acid accumulation in oilseed plants |
| 04/09/2008 | EP1819733A4 Monoclonal antibody to human tgf-beta induced gene-h3 and use thereof |
| 04/09/2008 | EP1778721B1 Modified hiv-1 peptides and use thereof in the detection of anti-hiv antibodies |
| 04/09/2008 | EP1697416B1 Purification of immunoglobulins |
| 04/09/2008 | EP1420032B1 Antibody recognizing gm1 ganglioside-bound amyloid beta-protein and dna encoding the antibody |
| 04/09/2008 | EP1394261A4 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence |
| 04/09/2008 | EP1140964B1 Connective tissue growth factor (ctgf) fragment |
| 04/09/2008 | EP1108784B1 Placental organic anion transporter and gene thereof |
| 04/09/2008 | EP1036175B1 Human brain derived kcnq2 potassium channel |
| 04/09/2008 | EP1027440B1 Inhibitor protein of the wnt signal pathway |
| 04/09/2008 | EP0972028B1 Mutants of vascular endothelial growth factor c (vegf-c) and uses thereof |
| 04/09/2008 | CN101160526A Antibody directed against gastrin-releasing peptide precursor and use thereof |
| 04/09/2008 | CN101160395A Phytase |
| 04/09/2008 | CN101160324A Monoclonal antibodies against prostate specific membrane antigen (psma) lacking in fucosyl residues |
| 04/09/2008 | CN101160320A Nucleophosmin protein (npm) mutants, corresponding gene sequences and uses thereof |
| 04/09/2008 | CN101160137A Use of CD 25antibody in immunity treatment |
| 04/09/2008 | CN101158681A Complementary type affinity chromatography purification method of autoantibody |
| 04/09/2008 | CN101157924A Neutrophil leukocyte gene alpha |
| 04/09/2008 | CN101157906A Phi BT1-TAT -NLS -HIS6 integrase and preparation method and application, polyclonal antibody and uses thereof |
| 04/09/2008 | CN101157727A Monoclonal antibody identifying waterfowl common IgY antigen and preparation method thereof |
| 04/09/2008 | CN100379862C Method of promoting homologous recombination of somatic cells and method of constructing specific antibody |
| 04/09/2008 | CN100379857C Chimeric animal and method for constructing the same |
| 04/09/2008 | CN100379856C Monocloned antibody against endothelial chalone and its hybrid tumor cell system and use |
| 04/09/2008 | CN100379855C Monkey monoclonal antibodies specific to human b. 7.1 and/or B7.2 primatized forms, pharmaceutical compositions |
| 04/09/2008 | CN100379758C Streptococcus pneumoniae antigens |
| 04/09/2008 | CN100379752C Antagonists of BMP and TGF beta signalling pathway |
| 04/09/2008 | CN100379751C Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 04/09/2008 | CN100379725C Immunoassay detection method for neonicotinyl insecticides |
| 04/08/2008 | US7355092 Lower cost passive immunization; promoting expression of fimbrial antigens |
| 04/08/2008 | US7355025 Marker molecules associated with lung tumors |
| 04/08/2008 | US7355018 human insulin-like growth factor-1 fusion polypeptide that includes a component capable of forming a multimer with another modified IGF-1 fusion polypeptide; useful for treating a muscle-related disease or condition, such as muscle atrophy |
| 04/08/2008 | US7355017 Fusion polypeptide for use in the treatment and prevention of graft rejection |
| 04/08/2008 | US7355016 Methods for detection of mycobacteria |
| 04/08/2008 | US7355015 Matriptase, a serine protease and its applications |
| 04/08/2008 | US7355014 Monoclonal antibody used to purify the interferon-gamma inducing polypeptide; antitumor agents |
| 04/08/2008 | US7355013 PRO6017 antibodies |
| 04/08/2008 | US7355012 Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells |
| 04/08/2008 | US7355011 Comprises chimeric antibodies for diagnosis and treatment of lymphomas; antitumor agents |
| 04/08/2008 | US7355010 Detecting, screening substrate; using enzyme activator; development of therapeutic drug |
| 04/08/2008 | US7355009 Antibodies to human Elk, a voltage-gated potassium channel subunit |
| 04/08/2008 | US7355008 Identification and engineering of antibodies with variant Fc regions and methods of using same |
| 04/08/2008 | US7355007 Antibodies that bind PRO5005 Polypeptides |
| 04/08/2008 | US7355006 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/08/2008 | US7355005 Recombinant chimeric Transmembrane Activator and Calcium-Signal Modulating Cyclophilin Ligand-Interactor protein that functions as a cell surface signaling protein; can thus be targeted to specifically regulate B cell responses without affecting mature T cell activity; autoimmune diseases |
| 04/08/2008 | US7355000 PRO1380 polypeptides |
| 04/08/2008 | US7354998 PRO7171 polypeptides |
| 04/08/2008 | US7354762 Transfecting with an expression vector containing DNA construct encoding chimeric receptor; electroporation; use in immunotherapy and treatment of neuroblastoma |
| 04/08/2008 | US7354759 Induce immunology response; antiproliferation agents; coding immoglobulins |
| 04/08/2008 | US7354738 isolated polypeptide modulates activity of nuclear receptor/ nuclear respiratory factor, brown adipose cell determination/differentiation, mitochondrial activity, biogenesis, fatty acid oxidation |
| 04/08/2008 | US7354736 Intracellular caspase inhibitory polypeptide for use in treatment and prevention of cell proliferative, nervous system and autoimmune disorders |
| 04/08/2008 | US7354724 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same |
| 04/08/2008 | US7354714 Production and applications for polyvalent vaccines against diseases caused by papilloma viruses |
| 04/08/2008 | US7354709 Diagnosing cancer in mammals; obtain sample cells, monitor expression of collapsin protein, amplified concentration of collapsin indicates cancer |
| 04/08/2008 | US7354588 Organ transplantation, tissue grafting, allergy, oncology, diagnosis, therapy |
| 04/08/2008 | US7354586 Treating arthritis by administering a therapeutically effective amount of an antibody immunospecific for av beta 3; antiarthritic agents;anticarcinogenic agents; antitumor agents; antimetastasis agents; antiinflammatory agents; antibody does not immunoreact with integrins other than av beta 3 |
| 04/08/2008 | US7354585 Methods of treating coagulapathic or thrombotic disorders |
| 04/08/2008 | US7354584 Recombinant IL-9 antibodies |
| 04/08/2008 | US7354583 Antibody-induced apoptosis |
| 04/08/2008 | US7354577 Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereof |